Infecção por E coli de origem alimentar

Referências

Principais artigos

Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev. 1998 Jan;11(1):142-201.Texto completo  Resumo

Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004 Feb;2(2):123-40.Texto completo  Resumo

Easton L. Escherichia coli O157: occurrence, transmission and laboratory detection. Br J Biomed Sci. 1997 Mar;54(1):57-64. Resumo

American Medical Association; American Nurses Association-American Nurses Foundation; Centers for Disease Control and Prevention; Center for Food Safety and Applied Nutrition, Food and Drug Administration; Food Safety and Inspection Service, US Department of Agriculture. Diagnosis and management of foodborne illnesses: a primer for physicians and other health care professionals. MMWR Recomm Rep. 2004 Apr 16;53(RR-4):1-33.Texto completo  Resumo

King CK, Glass R, Bresee JS, et al. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003;52:1-16.Texto completo  Resumo

World Health Organization. Foodborne disease outbreaks: guidelines for investigation and control. Geneva: WHO Press; 2008.Texto completo

Artigos de referência

1. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev. 1998 Jan;11(1):142-201.Texto completo  Resumo

2. Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004 Feb;2(2):123-40.Texto completo  Resumo

3. Garcia-Aljaro C, Momba M, Muniesa M; Global Water Pathogen Project. Pathogenic members of Escherichia coli & Shigella spp. Shigellosis. August 2018 [internet publication].Texto completo

4. Orskov F, Orskov I. Escherichia coli serotyping and disease in man and animals. Can J Microbiol. 1992 Jul;38(7):699-704. Resumo

5. Marder EP, Griffin PM, Cieslak PR, et al. Preliminary incidence and trends of infections with pathogens transmitted commonly through food: Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2006-2017. MMWR Morb Mortal Wkly Rep. 2018 Mar 23;67(11):324-8.Texto completo  Resumo

6. Lanata CF, Mendoza W; World Health Organization. Improving diarrhoea estimates. October 2002 [internet publication].Texto completo

7. Shah N, DuPont HL, Ramsey DJ. Global etiology of travelers' diarrhea: systematic review from 1973 to the present. Am J Trop Med Hyg. 2009 Apr;80(4):609-14. Resumo

8. Khalil IA, Troeger C, Blacker BF, et al. Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016. Lancet Infect Dis. 2018 Nov;18(11):1229-40.Texto completo  Resumo

9. Ochoa TJ, Barletta F, Contreras C, et al. New insights into the epidemiology of enteropathogenic Escherichia coli infection. Trans R Soc Trop Med Hyg. 2008 Sep;102(9):852-6.Texto completo  Resumo

10. Centers for Disease Control and Prevention. E. coli (Escherichia coli): questions and answers. February 2018 [internet publication].Texto completo

11. Rangel JM, Sparling PH, Crowe C, et al. Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002. Emerg Infect Dis. 2005 Apr;11(4):603-9.Texto completo  Resumo

12. Centers for Disease Control and Prevention. Reports of Selected E. coli Outbreak Investigations. 2021 [internet publication].Texto completo

13. Centers for Disease Control and Prevention. Outbreak of E. coli infections linked to romaine lettuce. January 2019 [internet publication].Texto completo

14. Meraz IM, Jiang ZD, Ericsson CD, et al. Enterotoxigenic Escherichia coli and diffusely adherent E coli as likely causes of a proportion of pathogen-negative travelers' diarrhea: a PCR-based study. J Travel Med. 2008 Nov-Dec;15(6):412-8.Texto completo  Resumo

15. Mead PS, Slutsker L, Dietz V, et al. Food-related illness and death in the United States. Emerg Infect Dis. 1999 Sep-Oct;5(5):607-25.Texto completo  Resumo

16. Easton L. Escherichia coli O157: occurrence, transmission and laboratory detection. Br J Biomed Sci. 1997 Mar;54(1):57-64. Resumo

17. David ST, MacDougall L, Louie K, et al. Petting zoo-associated Escherichia coli O157:h7 - secondary transmission, asymptomatic infection, and prolonged shedding in the classroom. Can Commun Dis Rep. 2004 Oct 15;30(20):173-80. Resumo

18. Ojeniyi AA. Direct transmission of Escherichia coli from poultry to humans. Epidemiol Infect. 1989 Dec;103(3):513-22.Texto completo  Resumo

19. Damborg P, Nielsen SS, Guardabassi L. Escherichia coli shedding patterns in humans and dogs: insights into within-household transmission of phylotypes associated with urinary tract infections. Epidemiol Infect. 2009 Oct;137(10):1457-64. Resumo

20. Erb A, Sturmer T, Marre R, et al. Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations. Eur J Clin Microbiol Infect Dis. 2007 Feb;26(2):83-90. Resumo

21. White DG, Zhao S, Simjee S, et al. Antimicrobial resistance of foodborne pathogens. Microbes Infect. 2002 Apr;4(4):405-12. Resumo

22. Day MJ, Hopkins KL, Wareham DW, et al. Extended-spectrum β-lactamase-producing Escherichia coli in human-derived and foodchain-derived samples from England, Wales, and Scotland: an epidemiological surveillance and typing study. Lancet Infect Dis. 2019 Dec;19(12):1325-35.Texto completo  Resumo

23. Mengistu DA, Tolera ST. Prevalence of Microorganisms of Public Health Significance in Ready-to-Eat Foods Sold in Developing Countries: Systematic Review and Meta-Analysis. Int J Food Sci. 2020 Nov 2:8867250.Texto completo  Resumo

24. Käferstein FK, Motarjemi Y, Bettcher DW. Foodborne disease control: a transnational challenge. Emerg Infect Dis. 1997 Oct-Dec;3(4):503-10.Texto completo  Resumo

25. Schlundt J. New directions in foodborne disease prevention. Int J Food Microbiol. 2002 Sep 15;78(1-2):3-17. Resumo

26. American Medical Association; American Nurses Association-American Nurses Foundation; Centers for Disease Control and Prevention; Center for Food Safety and Applied Nutrition, Food and Drug Administration; Food Safety and Inspection Service, US Department of Agriculture. Diagnosis and management of foodborne illnesses: a primer for physicians and other health care professionals. MMWR Recomm Rep. 2004 Apr 16;53(RR-4):1-33.Texto completo  Resumo

27. Riddle MS, Connor BA, Beeching NJ, et al. Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report. J Travel Med. 2017 Apr 1;24(suppl 1):S57-74.Texto completo  Resumo

28. Centers for Disease Control and Prevention. Guide to Confirming an Etiology in Foodborne Disease Outbreak. Oct 2015 [internet publication].Texto completo

29. Devleesschauwer B, Pires SM, Young I, et al. Associating sporadic, foodborne illness caused by Shiga toxin-producing Escherichia coli with specific foods: a systematic review and meta-analysis of case-control studies. Epidemiol Infect. 2019 Jul 8;147:e235.Texto completo  Resumo

30. Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-e80.Texto completo  Resumo

31. Clark SD, Sidlak M, Mathers AJ, et al. Clinical Yield of a Molecular Diagnostic Panel for Enteric Pathogens in Adult Outpatients With Diarrhea and Validation of Guidelines-Based Criteria for Testing. Open Forum Infect Dis.2019 Apr 16;6(4):ofz162.Texto completo  Resumo

32. Gould LH, Bopp C, Strockbine N, et al. Recommendations for diagnosis of shiga toxin--producing Escherichia coli infections by clinical laboratories. MMWR Recomm Rep. 2009 Oct 16;58(RR-12):1-14.Texto completo  Resumo

33. Barcenas CH & Ibrahim NK. Chemotherapy–Induced Colitis. In: Fukata M, ed. Colitis. Croatia, Rijeka: InTech; 2012:115-18.

34. King CK, Glass R, Bresee JS, et al. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003;52:1-16.Texto completo  Resumo

35. Aranda-Michel J, Giannella RA. Acute diarrhea: a practical review. Am J Med. 1999 Jun;106(6):670-6. Resumo

36. World Health Organization. Children: reducing mortality. September 2018 [internet publication].Texto completo

37. World Health Organization. Foodborne disease outbreaks: guidelines for investigation and control. Geneva: WHO Press; 2008.Texto completo

38. Figueroa-Quintanilla D, Salazar-Lindo E, Sack RB, et al. A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease. N Engl J Med. 1993 Jun 10;328(23):1653-8.Texto completo  Resumo

39. Soriano-Brucher H, Avendano P, O'Ryan M, et al. Bismuth subsalicylate in the treatment of acute diarrhea in children: a clinical study. Pediatrics. 1991 Jan;87(1):18-27. Resumo

40. Centers for Disease Control and Prevention. Enterotoxigenic E. coli (ETEC). Dec 2014 [internet publication].Texto completo

41. European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. Mar 2019 [internet publication].Texto completo

42. Wong CS, Jelacic S, Habeeb RL, et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. 2000;342:1930-1936. Resumo

43. Freedman SB, Xie J, Neufeld MS, et al. Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis. Clin Infect Dis. 2016 May 15;62(10):1251-8.Texto completo  Resumo

44. Murphy GS, Bodhidatta L, Echeverria P, et al. Ciprofloxacin and loperamide in the treatment of bacillary dysentery. Ann Intern Med. 1993 Apr 15;118(8):582-6. Resumo

45. Centers for Disease Control and Prevention. Yellow book: chapter 2 - travelers' diarrhea. Nov 2019 [internet publication].Texto completo

46. Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects. 21 March 2019 [internet publication].Texto completo

47. US Food & Drug Administration. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. 10 July 2018 [internet publication].Texto completo

48. US Food & Drug Administration. FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. 20 Dec 2018 [internet publication].Texto completo

49. S Food & Drug Administration. FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. 12 May 2016 [internet publication].Texto completo

50. Centers for Disease Control and Prevention. Yellow book: chapter 3 - Escherichia coli, diarrheagenic. May 2017 [internet publication].Texto completo

51. Sarker SA, Sultana S, Reuteler G, et al. Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh. EBioMedicine. 2016 Feb;4:124-37.Texto completo  Resumo

52. Ahmed A, Li J, Shiloach Y, et al. Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2-5-year-old children. J Infect Dis. 2006 Feb 15;193(4):515-21.Texto completo  Resumo

53. Frenck RW Jr, Ervin J, Chu L, et al. Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial. Lancet Infect Dis. 2019 Jun;19(6):631-40.Texto completo  Resumo

54. Dundas S, Todd WT, Stewart AI, et al. The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients. Clin Infect Dis. 2001 Oct 1;33(7):923-31.Texto completo  Resumo

55. Tserenpuntsag B, Chang HG, Smith PF, et al. Hemolytic uremic syndrome risk and Escherichia coli O157:H7. Emerg Infect Dis. 2005 Dec;11(12):1955-7.Texto completo  Resumo

56. Begue RE, Mehta DI, Blecker U. Escherichia coli and the hemolytic-uremic syndrome. South Med J. 1998 Sep;91(9):798-804. Resumo

57. World Health Organization. Factsheet: E. coli. February 2018 [internet publication].Texto completo

58. Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther. 2007 Aug 15;26(4):535-44.Texto completo  Resumo

59. Acheson DW, Fiore AE. Preventing foodborne disease - what clinicians can do. N Engl J Med. 2004 Jan 29;350(5):437-40. Resumo

O uso deste conteúdo está sujeito ao nosso aviso legal